Location# 011 — Lubbock, Texas

Location# 011 is a clinical research site located in Lubbock, Texas, United States 79410.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Location# 011 has participated in 1 clinical trials.

Therapeutic areas: Metastatic Colorectal Cancer.

Sponsors: Enzon Pharmaceuticals, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Lubbock

Browse all research sites in Texas · View every site in Lubbock

• Texas Tech University Heath Science Center
• Southwest Cancer and Research Center at University Medical Center
• Texas Tech University Health Sciences Center
• Texas Tech University Health Sciences Center-125 W Hague Rd- Site Number : 8400010
• Texas Tech University Health Science Center
• University Medical Center Cancer Center
• Texas Tech University
• Texas Tech University Plaza Building
• Texas Tech University Medical Center
• Texas Tech University Health Center
• Texas Tech University HSC
• Texas Tech University Health Sciences Center - Center for Cardiovascular Health

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Location# 011?

Location# 011 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Location# 011 conducted?

Location# 011 has 1 clinical trials on record. Their work covers Metastatic Colorectal Cancer.

Is Location# 011 accredited by Crixeo Clinical Trials?

Location# 011 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Location# 011?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.